Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Jump To

Synjardy

Brand names: Synjardy, Synjardy XR
Drug class: Antidiabetic combinations

Medically reviewed by  A Ras MD.

What is Synjardy?

Synjardy is a prescription medicine that contains 2 prescription diabetes medicines, empagliflozin and metformin. Synjardy can be used long with diet and exercise to improve blood sugar in adults with type 2 diabetes, in adults with type 2 diabetes who have known cardiovascular disease when both empagliflozin and metformin is appropriate and empagliflozin is needed to reduce the risk of cardiovascular death.

Synjardy is not for people with type 1 diabetes.

Synjardy is not for people with diabetic ketoacidosis (increased ketones in the blood or urine).

It is not known if Synjardy is safe and effective in children under 18 years of age.

Description

SYNJARDY tablets for oral use contain: empagliflozin and metformin hydrochloride.

 

Empagliflozin

Empagliflozin is an inhibitor of the sodium-glucose co-transporter 2 (SGLT2).

The chemical name of empagliflozin is D-Glucitol,1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-, (1S).

Its molecular formula is C23H27ClO7 and the molecular weight is 450.91. The structural formula is:

Chemical Structure

Empagliflozin is a white to yellowish, non-hygroscopic powder. It is very slightly soluble in water, sparingly soluble in methanol, slightly soluble in ethanol and acetonitrile; soluble in 50% acetonitrile/water; and practically insoluble in toluene.

Metformin hydrochloride

Metformin hydrochloride (N,N-dimethylimidodicarbonimidic diamide hydrochloride) is a biguanide. Metformin hydrochloride is a white to off-white crystalline compound with a molecular formula of C4H11N5∙HCl and a molecular weight of 165.63. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether, and chloroform. The pKa of metformin is 12.4. The pH of a 1% aqueous solution of metformin hydrochloride is 6.68. The structural formula is:

Chemical Structure

 

SYNJARDY

SYNJARDY tablets for oral administration are available in four dosage strengths containing 5 mg empagliflozin and 500 mg metformin hydrochloride, 5 mg empagliflozin and 1000 mg metformin hydrochloride, 12.5 mg empagliflozin and 500 mg metformin hydrochloride, or 12.5 mg empagliflozin and 1000 mg metformin hydrochloride.

Each film-coated tablet of SYNJARDY contains the following inactive ingredients: copovidone, corn starch, colloidal silicon dioxide, magnesium stearate. Film-coating: hypromellose, titanium dioxide, talc, polyethylene glycol 400, and yellow ferric oxide (5 mg/500 mg, 5 mg/1000 mg) or red ferric oxide and black ferrosoferric oxide (12.5 mg/500 mg, 12.5 mg/1000 mg).

Mechanism of Action

SYNJARDY

SYNJARDY contains: empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and metformin, a biguanide.

Empagliflozin

Sodium-glucose co-transporter 2 (SGLT2) is the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the circulation. Empagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose, and thereby increases urinary glucose excretion.

Metformin HCl

Metformin is an antihyperglycemic agent which improves glucose tolerance in patients with type 2 diabetes mellitus, lowering both basal and postprandial plasma glucose. It is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. Unlike SUs, metformin does not produce hypoglycemia in either patients with type 2 diabetes mellitus or normal subjects (except in special circumstances)  and does not cause hyperinsulinemia. With metformin therapy, insulin secretion remains unchanged while fasting insulin levels and day-long plasma insulin response may actually decrease.

What is the most important information I should know about Synjardy?

Serious side effects can happen in people taking Synjardy, including:

Lactic Acidosis. Metformin, one of the medicines in Synjardy can cause a rare but serious condition called lactic acidosis (a build-up of lactic acid in the blood) that can cause death. Lactic acidosis is a medical emergency and must be treated in a hospital.

Call your doctor right away if you have any of the following symptoms, which could be signs of lactic acidosis:

  • you feel cold in your hands or feet
  • you feel dizzy or lightheaded
  • you have a slow or irregular heartbeat
  • you feel very weak or tired
  • you have unusual (not normal) muscle pain
  • you have trouble breathing
  • you feel sleepy or drowsy
  • you have stomach pains, nausea or vomiting

Most people who have had lactic acidosis with metformin have other things that, combined with metformin, led to the lactic acidosis. Tell your doctor if you have any of the following, because you have a higher chance for getting lactic acidosis with Synjardy if you:

  • have moderate to severe kidney problems or your kidneys are affected by certain x-ray tests that use injectable dye.
  • have liver problems
  • drink alcohol very often, or drink a lot of alcohol in the short-term (“binge” drinking)
  • get dehydrated (lose a large amount of body fluids). This can happen if you are sick with a fever, vomiting, or diarrhea. Dehydration can also happen when you sweat a lot with activity or exercise and do not drink enough fluids.
  • have surgery
  • have a heart attack, severe infection, or stroke

The best way to keep from having a problem with lactic acidosis from metformin is to tell your doctor if you have any of the problems in the list above. Your doctor may decide to stop your Synjardy for a while if you have any of these things.

Synjardy can have other serious side effects. See “What are the possible side effects of Synjardy?”

Who should not take Synjardy?

Do not take Synjardy if you:

  • have moderate to severe kidney problems or are on dialysis
  • have a condition called metabolic acidosis or diabetic ketoacidosis (increased ketones in the blood or urine)
  • are allergic to empagliflozin, metformin, or any of the ingredients in Synjardy. See the end of this Medication Guide for a list of ingredients in Synjardy.

What should I tell my healthcare provider before taking Synjardy?

Before taking Synjardy, tell your healthcare provider about all of your medical conditions, including if you:

  • have moderate to severe kidney problems
  • have liver problems
  • have a history of urinary tract infection or problems with urination
  • have heart problems, including congestive heart failure
  • are going to have surgery. Your doctor may stop your Synjardy before you have surgery. Talk to your doctor if you are having surgery about when to stop taking Synjardy and when to start it again.
  • are eating less, or there is a change in your diet
  • have or have had problems with your pancreas, including pancreatitis or surgery on your pancreas
  • drink alcohol very often, or drink a lot of alcohol in the short term (“binge” drinking)
  • are going to get an injection of dye or contrast agents for an x-ray procedure. Synjardy may need to be stopped for a short time. Talk to your doctor about when you should stop Synjardy and when you should start Synjardy again. See “What is the most important information I should know about Synjardy?”
  • have type 1 diabetes. Synjardy should not be used to treat people with type 1 diabetes.
  • have any other medical conditions
  • are pregnant or plan to become pregnant. Synjardy may harm your unborn baby. If you become pregnant while taking Synjardy, tell your doctor as soon as possible. Talk with your doctor about the best way to control your blood sugar while you are pregnant.
  • are a premenopausal woman (before the “change of life”), who does not have periods regularly or at all. Talk to your doctor about birth control choices while taking Synjardy if you are not planning to become pregnant since Synjardy may increase your chance of becoming pregnant. Tell your doctor right away if you become pregnant while taking Synjardy.
  • are breastfeeding or plan to breastfeed. Synjardy may pass into your breast milk and may harm your baby. Talk with your doctor about the best way to feed your baby if you are taking Synjardy. Do not breastfeed while taking Synjardy.

Tell your healthcare provider about all the medicines you take, including prescription or over-the-counter medicines, vitamins, or herbal supplements.

How should I take Synjardy?

  • Take Synjardy exactly as your doctor tells you to take it.
  • Take Synjardy by mouth 2 times each day with meals. Taking Synjardy with meals may lower your chance of having an upset stomach.
  • Your doctor will tell you how much Synjardy to take and when to take it.
  • Your doctor may change your dose if needed.
  • If you miss a dose, take it as soon as you remember. If you do not remember until it is time for your next dose, skip the missed dose and go back to your regular schedule. Do not take two doses of Synjardy at the same time. Talk with your doctor if you have questions about a missed dose.
  • Your doctor may tell you to take Synjardy along with other diabetes medicines. Low blood sugar can happen more often when Synjardy is taken with certain other diabetes medicines. See “What are the possible side effects of Synjardy?”
  • If you take too much Synjardy, call your doctor or go to the nearest hospital emergency room right away.
  • When your body is under some types of stress, such as fever, trauma (such as a car accident), infection, or surgery, the amount of diabetes medicine that you need may change. Tell your doctor right away if you have any of these conditions and follow your doctor’s instructions.
  • Check your blood sugar as your doctor tells you to.
  • When taking Synjardy, you may have sugar in your urine, which will show up on a urine test.
  • Stay on your prescribed diet and exercise program while taking Synjardy.
  • Talk to your doctor about how to prevent, recognize and manage low blood sugar (hypoglycemia), high blood sugar (hyperglycemia), and complications of diabetes.
  • Your doctor will check your diabetes with regular blood tests, including your blood sugar levels and your hemoglobin A1C.
  • Your doctor will do blood tests to check how well your kidneys are working before and during your treatment with Synjardy.
  • Your doctor may do certain blood tests before you start Synjardy and during treatment.

What should I avoid while taking Synjardy?

Avoid drinking alcohol very often, or drinking a lot of alcohol in a short period of time (“binge” drinking). It can increase your chances of getting serious side effects.

What are the possible side effects of Synjardy?

Synjardy may cause serious side effects, including:

  • See “What is the most important information I should know about Synjardy?”
  • Dehydration. Synjardy can cause some people to have dehydration (the loss of body water and salt). Dehydration may cause you to feel dizzy, faint, light-headed, or weak, especially when you stand up (orthostatic hypotension).
    You may be at higher risk of dehydration if you:

    • have low blood pressure
    • have kidney problems
    • are 65 years of age or older
    • are on low sodium (salt) diet
    • take medicines to lower your blood pressure, including diuretics (water pills)
  • Ketoacidosis (increased ketones in your blood or urine). Ketoacidosis has happened in people who have type 1 diabetes or type 2 diabetes, during treatment with empagliflozin, one of the medicines in Synjardy. Ketoacidosis has also happened in people with diabetes who were sick or who had surgery during treatment with Synjardy. Ketoacidosis is a serious condition, which may need to be treated in a hospital. Ketoacidosis may lead to death. Ketoacidosis can happen with Synjardy even if your blood sugar is less than 250 mg/dL. Stop taking Synjardy and call your doctor right away if you get any of the following symptoms:
    • nausea
    • vomiting
    • stomach-area (abdominal) pain
    • tiredness
    • trouble breathing

If you get any of these symptoms during treatment with Synjardy, if possible, check for ketones in your urine, even if your blood sugar is less than 250 mg/dL.

  • Kidney problems. Sudden kidney injury has happened to people taking Synjardy. Talk to your doctor right away if you:
    • reduce the amount of food or liquid you drink for example, if you are sick or cannot eat or
    • start to lose liquids from your body for example, from vomiting, diarrhea or being in the sun too long
  • Serious urinary tract infections. Serious urinary tract infections that may lead to hospitalization have happened in people who are taking empagliflozin, one of the medicines in Synjardy. Tell your doctor if you have any signs or symptoms of a urinary tract infection such as a burning feeling when passing urine, a need to urinate often, the need to urinate right away, pain in the lower part of your stomach (pelvis), or blood in the urine. Sometimes people also may have a fever, back pain, nausea or vomiting.
  • Low blood sugar (hypoglycemia). If you take Synjardy with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin, your risk of getting low blood sugar is higher. The dose of your sulfonylurea medicine or insulin may need to be lowered while you take Synjardy. Signs and symptoms of low blood sugar may include:
    • headache
    • drowsiness
    • weakness
    • irritability
    • hunger
    • fast heartbeat
    • confusion
    • shaking or feeling jittery
    • dizziness
    • sweating
  • A rare but serious bacterial infection that causes damage to the tissue under the skin (necrotizing fasciitis) in the area between and around the anus and genitals (perineum). Necrotizing fasciitis of the perineum has happened in women and men who take empagliflozin, one of the medicines in Synjardy. Necrotizing fasciitis of the perineum may lead to hospitalization, may require multiple surgeries, and may lead to death. Seek medical attention immediately if you have a fever or you are feeling very weak, tired or uncomfortable (malaise), and you develop any of the following symptoms in the area between and around your anus and genitals:
    • pain or tenderness
    • swelling
    • redness of skin (erythema)
  • Vaginal yeast infection. Women who take Synjardy may get vaginal yeast infections. Symptoms of a vaginal yeast infection include vaginal odor, white or yellowish vaginal discharge (discharge may be lumpy or look like cottage cheese), or vaginal itching.
  • Yeast infection of the penis (balanitis). Men who take Synjardy may get a yeast infection of the skin around the penis. Certain men who are not circumcised may have swelling of the penis that makes it difficult to pull back the skin around the tip of the penis. Other symptoms of yeast infection of the penis include redness, itching, or swelling of the penis, rash of the penis, foul smelling discharge from the penis, or pain in the skin around the penis.
    Talk to your doctor about what to do if you get symptoms of a yeast infection of the vagina or penis. Your doctor may suggest you use an over-the-counter antifungal medicine. Talk to your doctor right away if you use an over-the-counter antifungal medication and your symptoms do not go away.
  • Allergic (hypersensitivity) reactions. Serious allergic reactions have happened in people who are taking empagliflozin, one of the medicines in Synjardy. Symptoms may include:
    • swelling of your face, lips, throat and other areas of your skin
    • difficulty with swallowing or breathing.
    • raised, red areas on your skin (hives)

If you have any of these symptoms, stop taking Synjardy and call your doctor right away or go to the nearest hospital emergency room.

  • Low vitamin B12 (vitamin B12 deficiency). Using metformin for long periods of time may cause a decrease in the amount of vitamin B12 in your blood, especially if you have had low vitamin B12 blood levels before. Your doctor may do blood tests to check your vitamin B12 levels.
  • Increased fats in your blood (cholesterol)

The most common side effects of Synjardy include stuffy or runny nose and sore throat.

These are not all the possible side effects of Synjardy. For more information, ask your doctor or pharmacist.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

General information about the safe and effective use of Synjardy

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use Synjardy for a condition for which it was not prescribed. Do not give Synjardy to other people, even if they have the same symptoms that you have. It may harm them.

This Medication Guide summarizes the most important information about Synjardy. If you would like more information, talk with your doctor. You can ask your pharmacist or healthcare provider for information about Synjardy that is written for health professionals.

How should I store Synjardy?

Store Synjardy at room temperature 68°F to 77°F (20°C to 25°C).

What are the ingredients in Synjardy?

Active Ingredients: empagliflozin and metformin hydrochloride

Inactive Ingredients: copovidone, corn starch, colloidal silicon dioxide, magnesium stearate. In addition, the film coating contains the following inactive ingredients: hypromellose, titanium dioxide, talc, and polyethylene glycol 400. 5 mg/500 mg and 5 mg/1000 mg tablets also contain yellow ferric oxide;12.5 mg/500 mg and 12.5 mg/1000 mg tablets also contain red ferric oxide and black ferrosoferric oxide

Label

PRINCIPAL DISPLAY PANEL – 5 MG/500 MG TABLET BOTTLE LABEL

 

  • NDC 0597-0159-60
  • DISPENSE WITH ACCOMPANYING
    MEDICATION GUIDE
  • Synjardy®
    (empagliflozin and
    metformin
    hydrochloride tablets)
  • 5 mg/500 mg
  • Rx only
  • 60 tablets
  • Boehringer
    Ingelheim
  • Lilly
PRINCIPAL DISPLAY PANEL - 5 mg/500 mg Tablet Bottle Label

Imprint Logo S5 500 - Synjardy empagliflozin 5 mg / metformin hydrochloride 500 mg

PRINCIPAL DISPLAY PANEL – 5 MG/1000 MG TABLET BOTTLE LABEL

  • NDC 0597-0175-60
  • DISPENSE WITH ACCOMPANYING
    MEDICATION GUIDE
  • Synjardy®
    (empagliflozin and
    metformin
    hydrochloride tablets)
  • 5 mg/1000 mg
  • Rx only
  • 60 tablets
  • Boehringer
    Ingelheim
  • Lilly
PRINCIPAL DISPLAY PANEL - 5 mg/1000 mg Tablet Bottle Label
Imprint Logo S5 1000 - Synjardy empagliflozin 5 mg / metformin hydrochloride 1000 mg

SRC: NLM .

Read Next Article